Bristol Myers Squibb (BMY) |
United States |
$136.042B |
9.43 |
Amgen (AMGN) |
United States |
$134.261B |
14.00 |
CSL (CSLLY) |
Australia |
$96.737B |
0.00 |
Gilead Sciences (GILD) |
United States |
$79.825B |
8.98 |
Illumina (ILMN) |
United States |
$67.776B |
103.23 |
Moderna (MRNA) |
United States |
$59.424B |
0.00 |
Vertex Pharmaceuticals (VRTX) |
United States |
$56.266B |
23.92 |
Regeneron Pharmaceuticals (REGN) |
United States |
$50.141B |
16.39 |
Biogen (BIIB) |
United States |
$42.514B |
8.50 |
Alexion Pharmaceuticals (ALXN) |
United States |
$33.621B |
13.09 |
BeiGene (BGNE) |
Cayman Islands |
$30.413B |
0.00 |
Seagen (SGEN) |
United States |
$28.448B |
48.77 |
BioNTech SE (BNTX) |
Germany |
$26.961B |
0.00 |
Genmab (GMAB) |
Denmark |
$24.055B |
28.45 |
Exact Sciences (EXAS) |
United States |
$23.455B |
0.00 |
Genmab (GNMSF) |
Denmark |
$21.894B |
5.04 |
SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$20.110B |
0.00 |
Bio-Rad Laboratories (BIO.B) |
United States |
$19.836B |
63.15 |
Horizon Therapeutics Public (HZNP) |
Ireland |
$18.601B |
26.59 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$17.926B |
0.00 |
Incyte (INCY) |
United States |
$17.372B |
0.00 |
ARGENX SE-ADR (ARGX) |
Netherlands |
$16.360B |
0.00 |
Guardant Health (GH) |
United States |
$16.011B |
0.00 |
Novavax (NVAX) |
United States |
$15.484B |
0.00 |
BioMarin Pharmaceutical (BMRN) |
United States |
$14.913B |
98.98 |
Bio-Techne Corp (TECH) |
United States |
$14.622B |
83.75 |
QIAGEN (QGEN) |
Netherlands |
$12.171B |
24.86 |
Repligen (RGEN) |
United States |
$10.866B |
154.11 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$10.206B |
0.00 |
Mirati Therapeutics (MRTX) |
United States |
$10.103B |
0.00 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$9.388B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$8.330B |
0.00 |
Acceleron Pharma (XLRN) |
United States |
$8.280B |
0.00 |
Ascendis Pharma (ASND) |
Denmark |
$8.167B |
0.00 |
Vir Biotechnology (VIR) |
United States |
$8.134B |
0.00 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$7.908B |
0.00 |
Adaptive Biotechnologies (ADPT) |
United States |
$7.763B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$7.753B |
0.00 |
Exelixis (EXEL) |
United States |
$6.931B |
63.47 |
Sarepta Therapeutics (SRPT) |
United States |
$6.614B |
0.00 |
Twist Bioscience (TWST) |
United States |
$6.581B |
0.00 |
Halozyme Therapeutics (HALO) |
United States |
$6.382B |
52.46 |
NeoGenomics (NEO) |
United States |
$5.883B |
1766.33 |
Blueprint Medicines (BPMC) |
United States |
$5.648B |
18.60 |
Beam Therapeutics (BEAM) |
United States |
$5.593B |
0.00 |
Galapagos (GLPG) |
Belgium |
$5.585B |
0.00 |
Certara (CERT) |
United States |
$5.547B |
0.00 |
SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.025B |
15.80 |
Emergent Biosolutions (EBS) |
United States |
$4.983B |
11.91 |
China Biologic Products (CBPO) |
China |
$4.715B |
30.56 |
Arena Pharmaceuticals (ARNA) |
United States |
$4.453B |
0.00 |
I-Mab (IMAB) |
China |
$4.137B |
0.00 |
Reata Pharmaceuticals (RETA) |
United States |
$4.131B |
0.00 |
Insmed (INSM) |
United States |
$4.002B |
0.00 |
Intellia Therapeutics (NTLA) |
United States |
$3.756B |
0.00 |
Legend Biotech (LEGN) |
United States |
$3.666B |
0.00 |
Arvinas (ARVN) |
United States |
$3.596B |
0.00 |
NantKwest (NK) |
United States |
$3.529B |
0.00 |
MorphoSys AG (MOR) |
Germany |
$3.405B |
123.24 |
Alkermes (ALKS) |
Ireland |
$3.129B |
0.00 |
Amicus Therapeutics (FOLD) |
United States |
$3.117B |
0.00 |
Editas Medicine (EDIT) |
United States |
$3.081B |
0.00 |
Global Blood Therapeutics (GBT) |
United States |
$2.968B |
0.00 |
Intra-Cellular Therapies (ITCI) |
United States |
$2.957B |
0.00 |
Viela Bio (VIE) |
United States |
$2.904B |
0.00 |
Sorrento Therapeutics (SRNE) |
United States |
$2.894B |
0.00 |
Amarin (AMRN) |
Ireland |
$2.811B |
0.00 |
Deciphera Pharmaceuticals (DCPH) |
United States |
$2.526B |
0.00 |
BAVARIAN NORDIC (BVNRY) |
Denmark |
$2.413B |
19.97 |
PHARMA MAR SA (PHMMF) |
Spain |
$2.401B |
0.00 |
Ligand Pharmaceuticals (LGND) |
United States |
$2.270B |
44.40 |
Genetron Holdings (GTH) |
China |
$2.262B |
0.00 |
Myriad Genetics (MYGN) |
United States |
$2.183B |
0.00 |
Inovio Pharmaceuticals (INO) |
United States |
$2.182B |
0.00 |
Arcus Biosciences (RCUS) |
United States |
$2.161B |
0.00 |
Vericel (VCEL) |
United States |
$2.152B |
0.00 |
Dicerna Pharmaceuticals (DRNA) |
United States |
$2.040B |
0.00 |
NGM Biopharmaceuticals (NGM) |
United States |
$1.947B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$1.921B |
0.00 |
Zymeworks (ZYME) |
Canada |
$1.881B |
0.00 |
Heska (HSKA) |
United States |
$1.858B |
0.00 |
Sangamo Therapeutics (SGMO) |
United States |
$1.744B |
0.00 |
Revance Therapeutics (RVNC) |
United States |
$1.724B |
0.00 |
Bluebird Bio (BLUE) |
United States |
$1.700B |
0.00 |
Antibe Therapeutics (ATBPF) |
Canada |
$1.672B |
0.00 |
Scholar Rock Holding (SRRK) |
United States |
$1.661B |
0.00 |
Castle Biosciences (CSTL) |
United States |
$1.648B |
0.00 |
Forma Therapeutics Holdings (FMTX) |
United States |
$1.640B |
0.00 |
Frequency Therapeutics (FREQ) |
United States |
$1.637B |
0.00 |
UniQure (QURE) |
Netherlands |
$1.610B |
0.00 |
Bionano Genomics (BNGO) |
United States |
$1.566B |
0.00 |
Precigen (PGEN) |
United States |
$1.534B |
0.00 |
Travere Therapeutics (TVTX) |
United States |
$1.514B |
0.00 |
REGENXBIO (RGNX) |
United States |
$1.499B |
0.00 |
Nurix Therapeutics (NRIX) |
United States |
$1.455B |
0.00 |
Cytokinetics (CYTK) |
United States |
$1.434B |
0.00 |
Alector (ALEC) |
United States |
$1.375B |
0.00 |
Zealand Pharma (ZEAL) |
Denmark |
$1.367B |
0.00 |
Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.330B |
0.00 |
Codexis (CDXS) |
United States |
$1.314B |
0.00 |
Mersana Therapeutics (MRSN) |
United States |
$1.305B |
0.00 |
Adverum Biotechnologies (ADVM) |
United States |
$1.299B |
0.00 |
MannKind (MNKD) |
United States |
$1.228B |
0.00 |
Pliant Therapeutics (PLRX) |
United States |
$1.211B |
0.00 |
Zealand Pharma (ZLDPF) |
Denmark |
$1.203B |
0.00 |
Mesoblast (MESO) |
Australia |
$1.188B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$1.170B |
7.73 |
Northwest Biotherapeutics (NWBO) |
United States |
$1.123B |
0.00 |
Athenex (ATNX) |
United States |
$1.111B |
0.00 |
Celldex Therapeutics (CLDX) |
United States |
$1.096B |
0.00 |
Morphic Holding (MORF) |
United States |
$1.061B |
0.00 |
MiMedx (MDXG) |
United States |
$1.058B |
0.00 |
Epizyme (EPZM) |
United States |
$1.057B |
0.00 |
OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.057B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$1.026B |
43.47 |
Avid Bioservices (CDMO) |
United States |
$1.015B |
0.00 |
ZIOPHARM Oncology Inc (ZIOP) |
United States |
$1.013B |
0.00 |
Dynavax Technologies (DVAX) |
United States |
$1.000B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$0.984B |
0.00 |
Cara Therapeutics (CARA) |
United States |
$0.981B |
0.00 |
Cellectis S.A (CLLS) |
France |
$0.932B |
0.00 |
Intercept Pharmaceuticals (ICPT) |
United States |
$0.928B |
0.00 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.921B |
0.00 |
Syndax Pharmaceuticals (SNDX) |
United States |
$0.911B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.902B |
0.00 |
Five Prime Therapeutics (FPRX) |
United States |
$0.891B |
0.00 |
Prothena (PRTA) |
Ireland |
$0.843B |
0.00 |
Sutro Biopharma (STRO) |
United States |
$0.841B |
0.00 |
Pharming Group (PHGUF) |
Netherlands |
$0.832B |
22.17 |
VBI Vaccines (VBIV) |
United States |
$0.816B |
0.00 |
Agenus (AGEN) |
United States |
$0.796B |
0.00 |
Kadmon Holdings (KDMN) |
United States |
$0.793B |
0.00 |
Pandion Therapeutics (PAND) |
United States |
$0.741B |
0.00 |
Cel-Sci (CVM) |
United States |
$0.732B |
0.00 |
AnaptysBio (ANAB) |
United States |
$0.730B |
0.00 |
Compugen (CGEN) |
Israel |
$0.719B |
0.00 |
Starpharma Holdings (SPHRY) |
Australia |
$0.711B |
0.00 |
ALBIREO PHARMA (ALBO) |
United States |
$0.702B |
0.00 |
Merus (MRUS) |
Netherlands |
$0.690B |
0.00 |
Orchard Therapeutics (ORTX) |
United Kingdom |
$0.666B |
0.00 |
Sinovac Biotech (SVA) |
China |
$0.640B |
35.94 |
Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.623B |
0.00 |
DBV Technologies S.A (DBVT) |
France |
$0.598B |
0.00 |
MeiraGTx Holdings (MGTX) |
United States |
$0.596B |
0.00 |
Geron (GERN) |
United States |
$0.596B |
0.00 |
ChromaDex (CDXC) |
United States |
$0.589B |
0.00 |
Curis (CRIS) |
United States |
$0.570B |
0.00 |
Xenon Pharmaceuticals (XENE) |
Canada |
$0.566B |
0.00 |
Precision BioSciences (DTIL) |
United States |
$0.565B |
0.00 |
Anika Therapeutics (ANIK) |
United States |
$0.542B |
73.27 |
AC Immune SA (ACIU) |
Switzerland |
$0.539B |
0.00 |
Clovis Oncology (CLVS) |
United States |
$0.531B |
0.00 |
CorMedix Inc (CRMD) |
United States |
$0.530B |
0.00 |
Amryt Pharma (AMYT) |
United Kingdom |
$0.519B |
0.00 |
AquaBounty Technologies (AQB) |
United States |
$0.519B |
0.00 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.516B |
0.00 |
Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.515B |
0.00 |
Neoleukin Therapeutics (NLTX) |
United States |
$0.515B |
0.00 |
AMMO (POWW) |
United States |
$0.514B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.509B |
0.00 |
Gritstone Oncology (GRTS) |
United States |
$0.508B |
0.00 |
Kala Pharmaceuticals (KALA) |
United States |
$0.505B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$0.474B |
0.00 |
Affimed (AFMD) |
Germany |
$0.465B |
0.00 |
Opthea (OPT) |
Australia |
$0.459B |
0.00 |
Selecta Biosciences (SELB) |
United States |
$0.452B |
0.00 |
UROGEN PHARMA (URGN) |
United States |
$0.449B |
0.00 |
IBio (IBIO) |
United States |
$0.436B |
0.00 |
Puma Biotechnology (PBYI) |
United States |
$0.433B |
0.00 |
Athersys (ATHX) |
United States |
$0.431B |
0.00 |
BioDelivery Sciences (BDSI) |
United States |
$0.427B |
20.12 |
Cue Biopharma (CUE) |
United States |
$0.408B |
0.00 |
Verastem (VSTM) |
United States |
$0.407B |
0.00 |
XOMA (XOMA) |
United States |
$0.396B |
0.00 |
Lineage Cell Therapeutics (LCTX) |
United States |
$0.385B |
0.00 |
Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.380B |
0.00 |
CytomX Therapeutics (CTMX) |
United States |
$0.370B |
0.00 |
Forte Biosciences (FBRX) |
United States |
$0.370B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.368B |
0.00 |
Cardiff Oncology (CRDF) |
United States |
$0.363B |
0.00 |
ANI Pharmaceuticals (ANIP) |
United States |
$0.360B |
9.16 |
Fortress Biotech (FBIO) |
United States |
$0.350B |
0.00 |
Trevena (TRVN) |
United States |
$0.344B |
0.00 |
Paratek Pharmaceuticals (PRTK) |
United States |
$0.344B |
0.00 |
Autolus Therapeutics (AUTL) |
United Kingdom |
$0.343B |
0.00 |
Aeglea BioTherapeutics (AGLE) |
United States |
$0.341B |
0.00 |
Innate Pharma S.A (IPHA) |
France |
$0.336B |
0.00 |
Arbutus Biopharma (ABUS) |
United States |
$0.325B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.320B |
0.00 |
NextCure (NXTC) |
United States |
$0.312B |
0.00 |
Bellus Health (BLU) |
Canada |
$0.302B |
0.00 |
Kamada (KMDA) |
Israel |
$0.291B |
16.74 |
PDL BioPharma (PDLI) |
United States |
$0.282B |
0.00 |
Cerecor (CERC) |
United States |
$0.275B |
0.00 |
Theratechnologies (THTX) |
Canada |
$0.274B |
0.00 |
OSMOTICA PHARM (OSMT) |
United States |
$0.260B |
0.00 |
HOOKIPA Pharma (HOOK) |
United States |
$0.251B |
0.00 |
AVEO Pharmaceuticals (AVEO) |
United States |
$0.249B |
0.00 |
Voyager Therapeutics (VYGR) |
United States |
$0.242B |
6.22 |
Aptinyx (APTX) |
United States |
$0.235B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$0.234B |
0.00 |
Nymox Pharmaceutical (NYMX) |
Canada |
$0.232B |
0.00 |
Applied Genetic Technologies (AGTC) |
United States |
$0.231B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.228B |
0.00 |
TELA Bio (TELA) |
United States |
$0.224B |
0.00 |
Strongbridge Biopharma (SBBP) |
United States |
$0.223B |
0.00 |
Eton Pharmaceuticals (ETON) |
United States |
$0.207B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.207B |
0.00 |
VolitionRX (VNRX) |
United States |
$0.205B |
0.00 |
Pluristem Therapeutics (PSTI) |
Israel |
$0.204B |
0.00 |
GENFIT S.A (GNFT) |
France |
$0.203B |
0.00 |
Exicure (XCUR) |
United States |
$0.201B |
0.00 |
POXEL SA FRANCE (PXXLF) |
France |
$0.197B |
0.00 |
Kindred Biosciences (KIN) |
United States |
$0.188B |
0.00 |
Protalix BioTherapeutics (PLX) |
Israel |
$0.184B |
0.00 |
Nicox SA (NICXF) |
France |
$0.184B |
0.00 |
Palatin Technologies (PTN) |
United States |
$0.182B |
0.00 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.177B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.175B |
0.00 |
Evogene (EVGN) |
Israel |
$0.170B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.169B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.169B |
350.00 |
Biofrontera AG (BFRA) |
Germany |
$0.168B |
0.00 |
Cogent Biosciences (COGT) |
United States |
$0.163B |
0.00 |
Seelos Therapeutics (SEEL) |
United States |
$0.162B |
0.00 |
Liminal BioSciences (LMNL) |
Canada |
$0.161B |
0.00 |
Dyadic (DYAI) |
United States |
$0.159B |
0.00 |
Idera Pharmaceuticals (IDRA) |
United States |
$0.152B |
0.00 |
Aptevo Therapeutics (APVO) |
United States |
$0.151B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.146B |
0.00 |
Enzo Biochem (ENZ) |
United States |
$0.144B |
0.00 |
Aytu Bioscience (AYTU) |
United States |
$0.141B |
0.00 |
Synlogic (SYBX) |
United States |
$0.141B |
0.00 |
CytRx (CYTR) |
United States |
$0.137B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.136B |
0.00 |
Cyclerion Therapeutics (CYCN) |
United States |
$0.134B |
0.00 |
TRACON Pharmaceuticals (TCON) |
United States |
$0.130B |
0.00 |
Catalyst Biosciences (CBIO) |
United States |
$0.130B |
0.00 |
ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.130B |
0.00 |
Beyond Air (XAIR) |
United States |
$0.128B |
0.00 |
Lumos Pharma (LUMO) |
United States |
$0.124B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.120B |
0.00 |
PHASEBIO PHARMA (PHAS) |
United States |
$0.118B |
0.00 |
Cocrystal Pharma (COCP) |
United States |
$0.115B |
0.00 |
Ecology Coatings (ABVC) |
United States |
$0.114B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.113B |
0.00 |
Cidara Therapeutics (CDTX) |
United States |
$0.109B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.108B |
0.00 |
CollPlant Biotechnologies (CLGN) |
Israel |
$0.107B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.105B |
0.00 |
Novogen (KZIA) |
Australia |
$0.103B |
0.00 |
Stealth BioTherapeutics (MITO) |
United States |
$0.100B |
45.25 |
Vascular Biogenics (VBLT) |
Israel |
$0.099B |
0.00 |
Advaxis (ADXS) |
United States |
$0.098B |
0.00 |
Adocia (ADOCY) |
France |
$0.092B |
0.00 |
Windtree Therapeutics (WINT) |
United States |
$0.089B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.089B |
0.00 |
Celsion (CLSN) |
United States |
$0.089B |
0.00 |
Aerpio Pharmaceuticals (ARPO) |
United States |
$0.084B |
0.00 |
Purple Biotech (PPBT) |
Israel |
$0.081B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.080B |
0.00 |
Emmaus Life Sciences (EMMA) |
United States |
$0.078B |
0.00 |
Sunesis Pharmaceuticals (SNSS) |
United States |
$0.077B |
0.00 |
AnPac Bio-Medical Science (ANPC) |
China |
$0.075B |
0.00 |
AEterna Zentaris (AEZS) |
United States |
$0.073B |
0.00 |
Cleveland BioLabs (CBLI) |
United States |
$0.073B |
0.00 |
ARIDIS PHARMACT (ARDS) |
United States |
$0.068B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.067B |
0.00 |
Edesa Biotech (EDSA) |
Canada |
$0.066B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.061B |
0.00 |
Enveric Biosciences (ENVB) |
United States |
$0.055B |
0.00 |
Soligenix (SNGX) |
United States |
$0.054B |
0.00 |
Appili Therapeutics (APLIF) |
Canada |
$0.054B |
0.00 |
Happiness Biotech Group (HAPP) |
China |
$0.054B |
0.00 |
BioCardia (BCDA) |
United States |
$0.053B |
0.00 |
Acorda Therapeutics (ACOR) |
United States |
$0.049B |
0.00 |
Yumanity Therapeutics (YMTX) |
United States |
$0.048B |
0.00 |
ATyr Pharma (LIFE) |
United States |
$0.047B |
0.00 |
Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.045B |
0.00 |
AIkido Pharma (AIKI) |
United States |
$0.044B |
0.00 |
Alimera Sciences (ALIM) |
United States |
$0.043B |
0.00 |
IMMURON (IMRN) |
Australia |
$0.039B |
0.00 |
Prana Biotechnology (ATHE) |
Australia |
$0.038B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.035B |
0.00 |
Lexaria Bioscience (LEXX) |
Canada |
$0.031B |
0.00 |
PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.030B |
0.00 |
Seneca Biopharma (SNCA) |
United States |
$0.025B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.024B |
0.00 |
ThermoGenesis Holdings (THMO) |
United States |
$0.024B |
0.00 |
GeoVax Labs (GOVX) |
United States |
$0.022B |
0.00 |
Timber Pharmaceuticals (TMBR) |
United States |
$0.020B |
0.00 |
Benitec Biopharma (BNTC) |
United States |
$0.018B |
0.00 |
Invo BioScience (INVO) |
United States |
$0.016B |
0.00 |
Cyclo Therapeutics (CYTH) |
United States |
$0.013B |
0.00 |
Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
Viridian Therapeutics (VRDN) |
United States |
$0.000B |
0.00 |
Zai Lab (ZLAB) |
China |
$0.000B |
0.00 |